LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory (Beta)
US
Oklahoma OK
Legislatures
2022 Regular Session
House
Bills
HB1013
OK
Oklahoma House Bill HB1013
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Meeting Calendar
Oklahoma 2022 Regular Session
Oklahoma House Bill HB1013
Introduced
2/1/21
Refer
2/2/21
Caption
Public health; prescription limits; opioid drugs; emergency.
Latest HB1013 Activity
Companion Bills
No companion bills found.
Similar Bills
NJ A3342
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.
NJ A2191
Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.
NJ A2260
Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.
NJ A3630
Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.
CA AB1998
Opioids: safe prescribing policy.
TX HB2174
Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.
OK SB605
Controlled dangerous substances; providing certain liability protections for prescription and dispensation of opioid drugs. Effective date.
NJ A2731
Expands prescription monitoring program to include veterinarians.